« Prilosec OTC: As Effective as Prescription Drugs for Heartburn and Acid Reflux Disease | Main | Cell Genesys, Inc.’s GVAX® Immunotherapy Passed Follow-Up Phase 2 Clinical Trial for Pancreatic Cancer »

Jan23
International Phase III Study Revealed That XELOX (Xeloda® + oxaliplatin) Equals FOLFOX in Overall Patient Survival From Advanced Colorectal Cancer

Clinical data (from an international phase III study: NO16966) presented at the American Society of Clinical Oncology Gastrointestinal Symposium (ASCO GI) in Orlando, Florida suggest that XELOX (Xeloda® + oxaliplatin) is an effective alternative to the current standard treatment for advanced (metastatic) colorectal cancer - FOLFOX-4 (infused 5-FU/leucovorin + oxaliplatin).

Xeloda.jpgXELOX, an abbreviation for a type of combination chemotherapy used to treat colorectal cancer, contains Roche’s Xeloda® (capecitabine), the only FDA-approved oral chemotherapy for metastatic breast cancer and metastatic colorectal cancer, plus oxaliplatin.

According to Professor Jim Cassidy, co-lead investigator for the study and Cancer Research UK Professor of Oncology and Chair of Medical Oncology, Beatson Oncology Centre, at the University of Glasgow, Scotland:

"These important survival results continue to affirm our initial hypothesis that XELOX is a viable, effective alternative to the current standard of care for advanced colorectal cancer.

These data underscore the tremendous promise of combinations using cornerstone therapies such as Xeloda, and the potential benefit of adding Avastin to achieve greater progression-free survival."

Find more details of the clinical data from the Roche press release.

1 Comments/Trackbacks




ARe there studies for xelox for pancreatic cancer?
Thank you I need the studies for my father to get the txment

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Prilosec OTC: As Effective as Prescription Drugs for Heartburn and Acid Reflux Disease | Main | Cell Genesys, Inc.’s GVAX® Immunotherapy Passed Follow-Up Phase 2 Clinical Trial for Pancreatic Cancer »

Advertise

Watch the Digital Health Revolution


Related Resources

recent comments

    sponsored ads



    subscribe


    Prefer Email?
    Subscribe below-

    Enter your Email:


    Powered by FeedBlitz What's this?

    Current News

    Support This Blog

    blogroll


    top blogs

    business social media

    Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

    BIZZlogos - Add your logo - free link to your site
    BIZZphotos - Add photos of your products and people
    BIZZprofiles - Submit your profile and build your online visibility
    BIZZspotlight - Spotlight your business with free links
    BIZZvideos - Videos about businesses, products and business people.
    BIZZbites - "Digg" for Business - Submit your articles and posts

    Know More Media - Health Care / Pharmaceutical / Fitness

    know more media network

    View Network Map

    Network Feed List (OPML)

    Know More Media Network
    Feed


    we support unitus

    PRWeb

    Influencer



    PharmaGazette is a member of the Know More Media network of business related blogs.

    Here are some current headlines from some of our business publications:

    ProductivityGoal

    CallCenterScript

    AdHurl

    TheBizofKnowledge

    LandingTheDeal

    CustomersAreAlways

    HealthCareVox

    BrainBasedBusiness

    TheInsurancePolicy

    MarketingBlurb